Olema Pharmaceuticals (OLMA) Amortizatization of Intangibles (2021 - 2023)
Olema Pharmaceuticals' (OLMA) quarterly Amortizatization of Intangibles came in at $869000.0 in Q1 2023, up 14583.33% year-on-year from N/an in Q1 2022, and up 52.19% on a QoQ basis from $571000.0 in Q4 2022.
Olema Pharmaceuticals (OLMA) Amortizatization of Intangibles (2021 - 2023) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 3 years of Amortizatization of Intangibles data on file, last reported at $869000.0 in Q1 2023.
- On a quarterly basis, Amortizatization of Intangibles rose 14583.33% year-over-year to $869000.0 in Q1 2023; TTM through Mar 2023 was $1.7 million, a 862.39% increase from a year earlier, with the FY2025 full-year figure at -$6.3 million, up 23.03% from the prior year.
- Amortizatization of Intangibles for Q1 2023 stood at $869000.0, up from $571000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for OLMA reached as high as $869000.0 in Q1 2023 and fell as low as -$82000.0 in Q3 2021.
- Historically, Amortizatization of Intangibles has averaged $153333.3 across 3 years, with a median of -$6000.0 in 2022.
- Across the five-year window, Amortizatization of Intangibles surged 90.62% in 2022 and soared 14583.33% in 2023, its largest moves.
- Year by year, Amortizatization of Intangibles stood at -$56000.0 in 2021, then soared by 1119.64% to $571000.0 in 2022, then soared by 52.19% to $869000.0 in 2023.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $869000.0 in Q1 2023, $571000.0 in Q4 2022, and $190000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Olema Pharmaceuticals | 1.26 Bn | 1.26 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 869,000.00 |
| Mar 31, 2023 | 869,000.00 |
| Dec 31, 2022 | 571,000.00 |
| Dec 31, 2022 | 571,000.00 |
| Sep 30, 2022 | 190,000.00 |
| Sep 30, 2022 | 190,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | -6,000.00 |
| Mar 31, 2022 | -6,000.00 |
| Dec 31, 2021 | -56,000.00 |
| Dec 31, 2021 | -56,000.00 |
| Sep 30, 2021 | -82,000.00 |
| Sep 30, 2021 | -82,000.00 |
| Jun 30, 2021 | -74,000.00 |
| Jun 30, 2021 | -74,000.00 |
| Mar 31, 2021 | -64,000.00 |
| Mar 31, 2021 | -64,000.00 |